Health economic analysis of distributional equity impacts – a call to action
Standard cost-effectiveness analysis (CEA) does not provide the information about distributional equity impacts that decision makers need to reduce unjust differences in health by socioeconomic status, ethnicity and other aspects of social disadvantage.
Tufts Analyzes Cost-Effectiveness Analysis for 1974-2018
Kim et. al. of Tufts Medical Center published an examination in the journal Pharmacoeconomics assessing CEA and Global Health CEA [...]
New Framework Introduces New Metric in Cost-Effectiveness Analysis
A recent article published in Value in Health proposes a new framework for valuing health outcomes in cost-effectiveness analyses and [...]
ISPOR Webinar to Spotlight Task Force Guidelines
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is set to host a webinar at 10:30 a.m. EST Jan. [...]
Advertisement
